Shmuel Ben Zvi
Direktor/Vorstandsmitglied bei BANK LEUMI LE-ISRAEL B.M.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Shmuel Ben Zvi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Direktor/Vorstandsmitglied | 29.07.2015 | - |
| Independent Dir/Board Member | 29.07.2015 | - | |
| PROTALIX BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 30.06.2022 | - |
| Independent Dir/Board Member | 30.06.2022 | - | |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - | - |
Karriereverlauf von Shmuel Ben Zvi
Ehemalige bekannte Positionen von Shmuel Ben Zvi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOTABLE LABS, LTD. | Direktor/Vorstandsmitglied | 01.09.2018 | 16.10.2023 |
| Independent Dir/Board Member | 01.09.2018 | 16.10.2023 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2004 | 01.12.2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01.01.2000 | 01.01.2004 |
| SOL-GEL TECHNOLOGIES LTD. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
| Independent Dir/Board Member | 01.01.2018 | - |
Ausbildung von Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Statistik
International
| Israel | 8 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
- Börse
- Insiders
- Shmuel Ben Zvi
- Erfahrung
